1. Home
  2. EE vs PHAR Comparison

EE vs PHAR Comparison

Compare EE & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Excelerate Energy Inc.

EE

Excelerate Energy Inc.

HOLD

Current Price

$39.35

Market Cap

1.2B

Sector

Utilities

ML Signal

HOLD

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

HOLD

Current Price

$11.85

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EE
PHAR
Founded
2003
1988
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Oil/Gas Transmission
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.0B
IPO Year
2022
2020

Fundamental Metrics

Financial Performance
Metric
EE
PHAR
Price
$39.35
$11.85
Analyst Decision
Buy
Strong Buy
Analyst Count
5
3
Target Price
$39.20
$38.33
AVG Volume (30 Days)
324.2K
19.9K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
0.96%
N/A
EPS Growth
0.79
N/A
EPS
0.75
N/A
Revenue
$1,228,263,000.00
N/A
Revenue This Year
$23.59
$10.04
Revenue Next Year
$24.37
$2.51
P/E Ratio
$52.48
$3,041.22
Revenue Growth
44.26
N/A
52 Week Low
$23.23
$9.62
52 Week High
$43.18
$21.34

Technical Indicators

Market Signals
Indicator
EE
PHAR
Relative Strength Index (RSI) 61.62 48.89
Support Level $32.03 $11.88
Resistance Level $40.00 $13.51
Average True Range (ATR) 1.47 0.59
MACD 0.27 0.13
Stochastic Oscillator 89.59 56.74

Price Performance

Historical Comparison
EE
PHAR

About EE Excelerate Energy Inc.

Excelerate Energy Inc. offers comprehensive LNG solutions by providing integrated services throughout the LNG value chain. The company delivers a full range of regasification services, including Floating Storage and Regasification Units (FSRUs), infrastructure development, and the supply of LNG and natural gas. With operational presence in several countries - Argentina, Bangladesh, Brazil, Finland, Germany, Pakistan, the United Arab Emirates (UAE), and the United States. The company generates revenue through Terminal Services, as well as from LNG, gas, and power. These revenues are derived from its vertically integrated activities in LNG sourcing, transportation, regasification, and power generation.

About PHAR Pharming Group N.V.

Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.

Share on Social Networks: